Fig. 1

Overexpression of XPO1 is associated with poor clinical characteristics and prognosis of neuroblastoma patients. AXPO1 mRNA is overexpressed in patients with age at diagnosis more than 18 months and B advanced INSS stage. C Patients with high XPO1 mRNA expression present shorter overall survival time. D panoramic view of TMA. E XPO1 protein is overexpressed in patients with age at diagnosis more than 18 months and F advanced INSS stage. G Patients with high XPO1 protein expression present shorter overall survival time. TMA, specimens and tissue microarray. INSS, International Neuroblastoma Staging System. ** P < 0.01, *** P < 0.001